Swara Baby Files DRHP for ₹1,000 Crore IPO to Fuel Expansion

Swara Baby, India's leading contract manufacturer of disposable hygiene products, has officially filed its Draft Red Herring Prospectus (DRHP) with SEBI to launch a ₹1,000 crore initial public offering. The company aims to leverage this capital to scale its manufacturing footprint and strengthen its market leadership in the baby and adult care segments.

IPO Structure and Strategic Fund Allocation

The proposed ₹1,000 crore IPO is split equally between a fresh issue of equity shares worth ₹500 crore and an Offer for Sale (OFS) of up to ₹500 crore. Within the OFS component, Brainbees Solutions Limited will sell shares worth up to ₹300 crore, while Anadya Bon Merchari LLP will offload up to ₹200 crore.

The company has outlined a clear roadmap for the fresh issue proceeds:

  • Capacity Expansion: ₹198.2 crore will be invested to establish a new manufacturing facility in Madhya Pradesh.
  • Debt Management: ₹100 crore will be used to repay or prepay existing borrowings, with an additional ₹27.5 crore allocated for debt repayment within its subsidiaries—Solis Hygiene, Swara Hygiene, and K.A. Enterprises Hygiene Private Limited (KAEHPL).
  • Growth & Acquisitions: The remaining funds are earmarked for inorganic growth through strategic acquisitions and general corporate purposes.

Dominant Market Position and Manufacturing Prowess

Since its inception in 2018, Swara Baby has ascended to become India's largest contract manufacturer of disposable hygiene products by value in FY25. The company holds a commanding 37% market share in the baby diaper contract manufacturing segment and a 36% share in the adult diaper segment.

Operating across 24 acres in Pithampur and Indore, Madhya Pradesh, the company has expanded from a single production line to 20 lines. Its massive installed annual capacity includes:

  • 2.66 billion baby diapers.
  • 253 million adult diapers and period panties.
  • 756 million sanitary napkins and panty liners.

Beyond contract manufacturing for giants like Piramal Pharma and Himalaya Wellness Company, Swara Baby is building its own brand equity through "Cuddles" (baby diapers) and "Shield" (adult diapers).

Robust Financial Trajectory and Innovation

Swara Baby’s financial performance reflects the rapid scaling of India's hygiene market. The company reported a significant revenue climb, reaching ₹1,163.9 crore in FY26, up from ₹942.97 crore in FY25. Profit after tax (PAT) also saw a healthy increase, rising to ₹95.58 crore in FY26 from ₹80.67 crore the previous year.

The product mix is heavily driven by baby care, which accounted for 79.06% of total product sales in FY26. To maintain its competitive edge, the company operates an in-house R&D center currently developing a patent-pending, plant-based "Tree Free" diaper. This focus on innovation aligns with a broader market trend, as India's hygiene sector is expected to grow at a 12.7% CAGR.

Key Takeaways

  • IPO Details: The ₹1,000 crore issue consists of a ₹500 crore fresh issue and a ₹500 crore OFS involving Brainbees Solutions and Anadya Bon Merchari.
  • Growth Drivers: Proceeds will primarily fund a new ₹198.2 crore manufacturing plant in Madhya Pradesh and strategic inorganic acquisitions.
  • Market Leadership: Swara Baby holds dominant market shares in both baby (37%) and adult (36%) diaper contract manufacturing segments.